The board approved "sale/transfer of the company's API facility situated at Plot Nos. 136, 137, 138, 139, 140, 141, 150, 151 & W‐152, MIDC, Tarapur, Boisar Dist. Thane, Maharashtra ‐ 401506, India."
The board also announced a notice of postal ballot seeking shareholders' approval for the proposed sale/transfer of the API facility.
Secondly, Grant Thornton Bharat was appointed as the company's internal auditors.
Sequent Scientific is a global pharmaceutical company specializing in Animal Health. With a strong international presence, the company operates in both API and formulation domains. Their focus lies in addressing unmet market needs for livestock, poultry, and companion animals.
Sequent Scientific reported net loss of Rs 34.85 crore in Q1 June 2023, higher than net loss of Rs 14.97 crore in Q1 June 2022. Net sales declined 2.38% YoY to Rs 333.21 crore in Q1 June 2023.
|